Carolien C H M Maas
8PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Nov 29, 2025
Diverging conclusions from risk difference and difference in restricted mean survival time in quantifying absolute treatment effect heterogeneity.Carolien C H M Maas, David M Kent, Avinash G Dinmohamed
|Sep 02, 2025
A Comprehensive Assessment of Plasma CXCL9 and CXCL10 in Improving Clinical Prediction Models for Kidney Allograft Rejection.Alvaro Assis de Souza, Dennis A Hesselink, Carolien C H M Maas
|Jan 07, 2025
Quantifying absolute treatment effect heterogeneity for time-to-event outcomes across different risk strata: divergence of conclusions with risk difference and restricted mean survival difference.Carolien C H M Maas, David M Kent, Avinash G Dinmohamed
|Sep 12, 2024
Comparative effectiveness of 6x R-CHOP21 versus 6x R-CHOP21 + 2 R for patients with advanced-stage diffuse large B-cell lymphoma.Carolien C H M Maas, David van Klaveren, Müjde Durmaz
|May 20, 2024
Potential clinical impact of predictive modeling of heterogeneous treatment effects: scoping review of the impact of the PATH Statement.Joe V Selby, Carolien C H M Maas, Bruce H Fireman
Pageof 2
Frequent Collaborators
6 joint publications
David van Klaveren
5 joint publications
David M Kent
4 joint publications
Avinash G Dinmohamed
1 joint publications
Geneviève I C G Ector
1 joint publications
Müjde Durmaz
1 joint publications
Martine E D Chamuleau
1 joint publications
Marie José Kersten
1 joint publications
Alvaro Assis de Souza
1 joint publications
Dennis A Hesselink
1 joint publications
Andrew P Stubbs